Erratum to 'Oxaliplatin, 5-Fluorouracil and Nab-paclitaxel as perioperative regimen in patients with resectable gastric adenocarcinoma: A GERCOR phase II study (FOXAGAST)' [Eur J Cancer 107 (January 2019) 46-52]

Affiliations

• ¹ Medical Oncology Department, Institut Mutualiste Montsouris, Paris, France.
• ² Medical Oncology Department, Centre Léon Bérard, Lyon, France.
• ³ Medical Oncology Department, Centre Hospitalier Régional Universitaire, Besançon, France.
• ⁴ Sorbonne Université, Medical Oncology Department, AP-HP, Hôpital Saint-Antoine, F-75012 Paris, France.
• ⁵ Sorbonne Universités, UPMC, Gastro-enterology Department, Hôpital de la Pitié-Salpêtrière, Assistance Publique - Hôpitaux de Paris, Paris, France.
• ⁶ Medical Oncology Department, Hôpital Henri Mondor, Assistance Publique - Hôpitaux de Paris, UPEC, Créteil, France.
• ⁷ Surgical Department, Institut Mutualiste Montsouris, Paris, France.
• ⁸ Pathology Department, Institut Mutualiste Montsouris, Paris, France.
• ⁹ Sorbonne Université, UPMC, Pathology Department, Hôpital Saint-Antoine, Assistance Publique - Hôpitaux de Paris, Paris, France.
• ¹⁰ Methodological and Quality of Life in Oncology Unit, Centre Hospitalier Régional Universitaire, Besançon, France.
• ¹¹ Medical Oncology Department, Institut Mutualiste Montsouris, Paris, France. Electronic address: [email protected].